Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Company

Ant Insurance Reports 23% Surge in Health Insurance Payouts, Processing 4.69 Million Claims in 2023

October 27, 2024
CompanyDeals

Myrobalan Therapeutics Secures $24 Million in Series A Funding with Strong Chinese Investor Support

October 27, 2024
CompanyDrug

Huadong Medicine’s Relmapirazin Approval Filing Accepted by NMPA for GFR Measurement

October 27, 2024
CompanyMedical Device

Lepu Medical Secures NMPA Approval for Innovative Coronary Intravascular Impact Waveguide Tube

October 27, 2024
CompanyDeals

CORXEL Secures Licensing Rights for Biogen’s BIIB131 in Stroke Treatment

November 29, 2024
Company

Boehringer Ingelheim Expands Greek Facility to Boost Production of Jardiance and Other Medications

October 27, 2024
Company

Fosun Kite and Medi Cover Launch First Value-Based Payment Plan for Lymphoma Treatment

December 9, 2024
CompanyDrug

Novo Nordisk’s IcoSema Shows Promise in Late-Stage Trial for Type 2 Diabetes Management

October 27, 2024
CompanyDrug

AbbVie’s Lutikizumab Advances to Phase III for Hidradenitis Suppurativa After Positive Mid-Stage Results

October 27, 2024
Company

Changchun High & New Technology to Transfer 7.42% Stake to Ex-Wife in Divorce Settlement

December 24, 2024
CompanyDrug

Bio-Thera Solutions Receives NMPA Approval for Combined Phase Ib/II Study of BAT7104 and BAT4706

October 27, 2024
CompanyDrug

Eisai’s Lemborexant Sleep Aid Lemborexant Filed for NMPA Approval in China

October 27, 2024
1 2 … 15 16 17 18 19 … 27 28
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up